XML 84 R73.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments And Contingencies (Legal Proceedings and Investigations) (Narrative) (Details)
$ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended 13 Months Ended
Oct. 31, 2016
case
Sep. 30, 2016
USD ($)
Feb. 29, 2016
USD ($)
Oct. 31, 2015
motion
Aug. 31, 2015
Sep. 30, 2013
company
Feb. 28, 2013
Sep. 30, 2016
USD ($)
study_order
case
Dec. 31, 2012
patent
Oct. 30, 2013
Nov. 01, 2016
case
Dec. 31, 2015
USD ($)
Loss Contingencies [Line Items]                        
Reserve for loss contingencies   $ 1,280,000           $ 1,280,000        
Current portion of legal settlement accrual   1,280,785           1,280,785       $ 1,606,726
Vaginal mesh cases | AMS                        
Loss Contingencies [Line Items]                        
Product liability accrual, period expense   1,200,000           $ 1,200,000        
Number of class-wide post-market study orders received | study_order               19        
Number of class-wide post-market study orders placed on hold by the FDA | study_order               16        
Number of active class-wide post-market study orders | study_order               3        
Loss contingency, claims settled, number | case               49,000        
Settlement amount               $ 2,800,000        
Lawsuits filed | case               8,000        
Testosterone cases | Subsequent Event                        
Loss Contingencies [Line Items]                        
Pending claims, number | case                     1,140  
Vaginal mesh cases                        
Loss Contingencies [Line Items]                        
Current portion of legal settlement accrual   1,200,000           $ 1,200,000        
Unapproved Drug Litigation                        
Loss Contingencies [Line Items]                        
Number of additional pharmaceutical companies named in petitions (over 50) | company           50            
Megace ES Cases                        
Loss Contingencies [Line Items]                        
Damages sought per violation     $ 16,000                  
Megace ES Cases | PPI                        
Loss Contingencies [Line Items]                        
Damages awarded   $ 12,700                    
Opana                        
Gain Contingencies [Line Items]                        
Lawsuit filing period                   45 days    
Stay of approval period, Hatch-Waxman Act                   30 months    
Opana | Subsequent Event                        
Loss Contingencies [Line Items]                        
Lawsuits filed | case 2                      
Opana | Judicial Ruling                        
Gain Contingencies [Line Items]                        
Number of patents found infringed upon | patent                 2      
Period for generic product to be withdrawn       60 days 60 days              
Number of post-trial motions | motion       2                
Paragraph IV Certification on Fortesta Gel [Member]                        
Gain Contingencies [Line Items]                        
Lawsuit filing period             45 days          
Stay of approval period, Hatch-Waxman Act             30 months